These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9668677)

  • 1. Methamphetamine treatment affects blood and liver S-adenosylmethionine (SAM) in mice. Correlation with dopamine depletion in the striatum.
    Cooney CA; Wise CK; Poirier LA; Ali SF
    Ann N Y Acad Sci; 1998 May; 844():191-200. PubMed ID: 9668677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine Treatment Affects Blood and Liver S-Adenosylmethionine (SAM) in Mice: Correlation with Dopamine Depletion in the Striatum
    Cooney CA; Wise CK; Poirier LA; Ali SF
    Ann N Y Acad Sci; 1998 May; 844(1):191-200. PubMed ID: 29090801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
    Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
    J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective regional response of cultured astrocytes to methamphetamine.
    Stadlin A; Lau JW; Szeto YK
    Ann N Y Acad Sci; 1998 May; 844():108-21. PubMed ID: 9668669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism.
    Horner KA; Westwood SC; Hanson GR; Keefe KA
    J Pharmacol Exp Ther; 2006 Oct; 319(1):414-21. PubMed ID: 16840646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced spectrin proteolysis in the rat striatum.
    Staszewski RD; Yamamoto BK
    J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex.
    Simões PF; Silva AP; Pereira FC; Marques E; Milhazes N; Borges F; Ribeiro CF; Macedo TR
    Ann N Y Acad Sci; 2008 Oct; 1139():232-41. PubMed ID: 18991869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
    Kitamura O
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Smith MP; Peters LE
    Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
    Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.
    Martins T; Baptista S; Gonçalves J; Leal E; Milhazes N; Borges F; Ribeiro CF; Quintela O; Lendoiro E; López-Rivadulla M; Ambrósio AF; Silva AP
    Brain Res; 2011 Sep; 1411():28-40. PubMed ID: 21803344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
    Bowyer JF; Robinson B; Ali S; Schmued LC
    Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain.
    Gonçalves J; Martins T; Ferreira R; Milhazes N; Borges F; Ribeiro CF; Malva JO; Macedo TR; Silva AP
    Ann N Y Acad Sci; 2008 Oct; 1139():103-11. PubMed ID: 18991854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.